Neurocrine (NBIX)

Neurocrine (NBIX) Financial Statements


Neurocrine Financial Overview

Neurocrine's market cap is currently ―. The company's EPS TTM is $1.869; its P/E ratio is 62.66; Neurocrine is scheduled to report earnings on February 6, 2024, and the estimated EPS forecast is $1.22. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 498.80M$ 452.70M$ 420.40M$ 412.00M$ 387.90M
Gross Profit$ 487.60M$ 441.20M$ 411.90M$ 404.30M$ 381.80M
EBIT$ 116.70M$ 122.90M$ -102.20M$ 110.60M$ 99.10M
EBITDA$ 122.40M$ 128.20M$ -97.00M$ 115.20M$ 103.10M
Net Income Common Stockholders$ 83.10M$ 95.50M$ -76.60M$ 89.00M$ 68.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.10B$ 976.70M$ 894.60M$ 989.30M$ 799.40M
Total Assets$ 2.85B$ 2.61B$ 2.36B$ 2.37B$ 2.14B
Total Debt$ 255.80M$ 258.80M$ 259.90M$ 262.90M$ 265.80M
Net Debt$ -839.30M$ -717.90M$ -634.70M$ -726.40M$ -533.60M
Total Liabilities$ 846.10M$ 760.10M$ 675.30M$ 2.37B$ 598.80M
Stockholders Equity$ 2.00B$ 1.85B$ 1.68B$ 1.71B$ 1.54B
Cash Flow-
Free Cash Flow$ 204.40M$ 172.80M$ -133.70M$ 141.20M$ 100.50M
Operating Cash Flow$ 212.00M$ 179.60M$ -125.20M$ 143.00M$ 98.80M
Investing Cash Flow$ -97.30M$ -125.90M$ -42.10M$ -115.60M$ -61.30M
Financing Cash Flow$ 18.80M$ 2.90M$ 8.20M$ 24.60M$ 11.40M
Currency in USD

Neurocrine Earnings and Revenue History

Neurocrine Debt to Assets

Neurocrine Cash Flow

Neurocrine Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis